The Beauty Health Company
SKIN
$1.40
-$0.06-4.11%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -10.34% | -13.70% | -14.52% | -13.76% | -19.11% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -10.34% | -13.70% | -14.52% | -13.76% | -19.11% |
| Cost of Revenue | -34.42% | -41.44% | -36.44% | -39.08% | -65.30% |
| Gross Profit | 12.26% | 19.96% | 0.45% | 14.58% | 423.82% |
| SG&A Expenses | -17.82% | -18.31% | -4.70% | -4.46% | -9.83% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -23.35% | -28.23% | -17.07% | -21.30% | -44.12% |
| Operating Income | 70.99% | 87.79% | 29.24% | 61.02% | 73.79% |
| Income Before Tax | 34.87% | 12,496.69% | -587.89% | -33.16% | 76.77% |
| Income Tax Expenses | -80.18% | -181.30% | 235.36% | -330.18% | -44.01% |
| Earnings from Continuing Operations | 39.69% | 9,658.42% | -1,386.89% | -9.86% | 75.22% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 39.69% | 9,658.42% | -1,386.89% | -9.86% | 75.22% |
| EBIT | 70.99% | 87.79% | 29.24% | 61.02% | 73.79% |
| EBITDA | 118.32% | 120.47% | 29.77% | 92.87% | 83.86% |
| EPS Basic | 41.04% | 9,675.00% | -1,367.27% | -13.54% | 73.47% |
| Normalized Basic EPS | 36.33% | 103.51% | 48.02% | -37.94% | 76.74% |
| EPS Diluted | 40.00% | 129.17% | 15.23% | -8.36% | 73.21% |
| Normalized Diluted EPS | 36.33% | 103.65% | 38.99% | -37.94% | 76.74% |
| Average Basic Shares Outstanding | 2.28% | 1.90% | 1.59% | -3.35% | -6.65% |
| Average Diluted Shares Outstanding | 2.28% | -1.15% | -13.43% | -3.35% | -6.65% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |